TerraPower and POINT Biopharma signed a supply agreement for the medical radioisotope actinium-225. Together, we can accelerate the development of pharmaceuticals using actinium-225 and bring this material to patients in need of life-saving cancer therapy.
Source: Yahoo! Finance
